Literature DB >> 25642976

A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis.

Al-Rahim R Habib1, Jamil Manji, Pearce G Wilcox, Amin R Javer, Jane A Buxton, Bradley S Quon.   

Abstract

RATIONALE: As the life expectancy for individuals with cystic fibrosis (CF) continues to improve, an emphasis on optimizing health-related quality of life (HRQoL) has become increasingly important. The Cystic Fibrosis Questionnaire-Revised (CFQ-R 14+) is the most widely accepted method to quantify HRQoL in this patient population.
OBJECTIVES: Our objective was to systematically review the literature to identify sociodemographic and clinical factors associated with HRQoL among adolescents and adults with CF.
METHODS: Five major literature databases were searched (MEDLINE, EMBASE, CENTRAL, CINAHL, psychINFO) to identify studies published from January 1989 to April 2014 (n=1,921). We included all full-text studies that: (1) focused on individuals 14 years of age or older, and (2) examined the relationship between sociodemographic (age, sex, body-mass index [BMI], socioeconomic status, and employment) and clinical (FEV1 % predicted, pulmonary exacerbation, comorbidities) factors with the CFQ-R 14+. Effect estimates and levels of statistical significance in the association between sociodemographic and clinical factors with each of the 12 CFQ-R 14+ domains were analyzed, if examined in at least two studies.
MEASUREMENTS AND MAIN RESULTS: Twenty-eight articles met our inclusion/exclusion criteria, but 5 studies were excluded at the data synthesis stage, leaving 23 articles for analysis. In relation to the CFQ-R 14+, 10 candidate factors were examined in at least two studies. The five most commonly studied factors were FEV1 % predicted (57.1% of 28 studies), sex (32.1%), BMI (28.6%), age (17.6%), and pulmonary exacerbations (13%). In studies incorporating multivariable methods, FEV1 % predicted was positively associated with all CFQ-R 14+ domains with the exception of Digestion, Social Functioning, and Emotional Functioning. Male subjects reported higher Physical Functioning and lower Body Image scores than female subjects, BMI was positively correlated with Body Image and Weight, and age was negatively correlated with Treatment Burden. Pulmonary exacerbations were negatively associated with multiple domains, including Respiratory Symptoms, Physical, and Role Functioning.
CONCLUSIONS: Although several factors have been found to be associated with the CFQ-R in adolescents and adults with CF, FEV1 % predicted and pulmonary exacerbations have the broadest impact on HRQoL. Further research is required to investigate the impact of age-related comorbidities, psychosocial factors, and treatment-related factors on HRQoL in adolescents/adults with cystic fibrosis.

Entities:  

Keywords:  cystic fibrosis; quality of life; review

Mesh:

Year:  2015        PMID: 25642976     DOI: 10.1513/AnnalsATS.201408-393OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  24 in total

1.  Bespoke Babies: Genome Editing in Cystic Fibrosis Embryos.

Authors:  Kyle B Brothers; Mary Devereaux; Robert M Sade
Journal:  Ann Thorac Surg       Date:  2019-05-29       Impact factor: 4.330

2.  Exercise performance and quality of life in children with cystic fibrosis and mildly impaired lung function: relation with antibiotic treatments and hospitalization.

Authors:  Kristof Vandekerckhove; Michiel Keyzer; Jasper Cornette; Ilse Coomans; Filip Pyl; Frans De Baets; Petra Schelstraete; Filomeen Haerynck; Daniel De Wolf; Sabine Van Daele; Jan Boone
Journal:  Eur J Pediatr       Date:  2017-09-30       Impact factor: 3.183

Review 3.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

4.  Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.

Authors:  Robert A Quinn; Yan Wei Lim; Tytus D Mak; Katrine Whiteson; Mike Furlan; Douglas Conrad; Forest Rohwer; Pieter Dorrestein
Journal:  PeerJ       Date:  2016-08-11       Impact factor: 2.984

5.  Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.

Authors:  Rodrigo Abensur Athanazio; Luiz Vicente Ribeiro Ferreira da Silva Filho; Alberto Andrade Vergara; Antônio Fernando Ribeiro; Carlos Antônio Riedi; Elenara da Fonseca Andrade Procianoy; Fabíola Villac Adde; Francisco José Caldeira Reis; José Dirceu Ribeiro; Lídia Alice Torres; Marcelo Bicalho de Fuccio; Matias Epifanio; Mônica de Cássia Firmida; Neiva Damaceno; Norberto Ludwig-Neto; Paulo José Cauduro Maróstica; Samia Zahi Rached; Suzana Fonseca de Oliveira Melo
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

Review 6.  PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy.

Authors:  Dave P Nichols; Scott H Donaldson; Carla A Frederick; Steven D Freedman; Daniel Gelfond; Lucas R Hoffman; Andrea Kelly; Michael R Narkewicz; Jessica E Pittman; Felix Ratjen; Scott D Sagel; Margaret Rosenfeld; Sarah Jane Schwarzenberg; Pradeep K Singh; George M Solomon; Michael S Stalvey; Shannon Kirby; Jill M VanDalfsen; John P Clancy; Steven M Rowe
Journal:  J Cyst Fibros       Date:  2021-02-19       Impact factor: 5.482

7.  Optimising treatment of CF pulmonary exacerbation: a tough nut to crack.

Authors:  Sonya L Heltshe; Christopher H Goss
Journal:  Thorax       Date:  2016-02       Impact factor: 9.102

8.  The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis.

Authors:  Andrea Granados; Elizabeth A Beach; Andrew J Christiansen; Bruce W Patterson; Michael Wallendorf; Ana María Arbeláez
Journal:  J Cyst Fibros       Date:  2021-06-26       Impact factor: 5.527

9.  Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis.

Authors:  Caitlyn T Solem; Montserrat Vera-Llonch; Sizhu Liu; Marc Botteman; Brenda Castiglione
Journal:  Health Qual Life Outcomes       Date:  2016-04-21       Impact factor: 3.186

10.  Yoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study.

Authors:  Jennifer Ruddy; Julia Emerson; Sharon McNamara; Alan Genatossio; Cora Breuner; Tracy Weber; Margaret Rosenfeld
Journal:  Glob Adv Health Med       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.